Friday 6 November 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue: +8.69%
EPS: +56.7%
Free cash flow: +12.3%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

392.97 15.81 −3.87%

Follow WST

Alert me

Market cap: $27.3B
P/E: 43.8×
Fwd P/E: 48.1×
Dividend yield: 0.22%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	41.33	45.62	33.33	40.28	+8 more quarters Free account
P/S ratio Full definition →	7.68	7.64	5.60	6.47
P/FCF ratio Full definition →	58.05	58.69	39.73	42.77
P/Operating CF Full definition →	137.74	204.98	200.74	79.22
P/B ratio Full definition →	8.79	8.50	6.03	6.26
Price to Tangible BV Full definition →	9.15	8.84	6.28	6.50
EV/Sales Full definition →	7.61	7.57	5.50	6.28
EV/EBITDA Full definition →	26.79	29.22	21.32	25.52
EV/Operating CF Full definition →	39.48	38.03	24.78	25.58
EV/FCF Full definition →	57.47	58.15	39.03	41.51
Quick Ratio Full definition →	1.88	1.79	1.79	2.09
Current Ratio Full definition →	2.82	2.82	2.71	3.02
Net Debt/EBITDA Full definition →	(0.83)	(1.03)	(1.43)	(2.89)
Debt/Assets Full definition →	5.00%	4.98%	4.93%	4.75%
Debt/Equity Full definition →	0.07	0.07	0.07	0.06
Asset Turnover Full definition →	0.83	0.83	0.83	0.78
Operating CF/Net income Full definition →	0.89	0.81	0.65	1.90
Capex/Depreciation Full definition →	(0.85)	(0.94)	(0.94)	(1.62)
Interest Coverage Full definition →	70.37	68.88	93.21	(783.00)
Research and Development Expense of Revenue Full definition →	2.09%	2.26%	1.87%	2.71%
Selling, General and Administrative Expense of Revenue Full definition →	12.91%	13.48%	11.78%	13.29%
Intangible Assets out of Total Assets Full definition →	0.03	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →	0.49%	1.25%	0.78%	0.83%
Graham Net Nets Full definition →	0.03	0.03	0.04	0.04
Graham Number Full definition →	92.25	86.48	83.83	82.16
Earnings Yield Full definition →	2.42%	2.19%	3.00%	2.48%
Free Cash Flow Yield Full definition →	1.72%	1.70%	2.52%	2.34%
Revenue per Share Full definition →	12.42	12.32	11.73	11.13
Operating CF per Share Full definition →	2.69	1.75	1.25	3.47
Capex per Share Full definition →	(0.56)	(0.61)	(0.59)	(1.05)
Free Cash Flow per Share Full definition →	2.14	1.14	0.66	2.42
Cash per Share Full definition →	6.59	6.16	7.24	10.94
Shareholders Equity per Share Full definition →	42.16	42.23	41.53	43.93
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	42.16	42.23	41.53	43.93
Free Cash Flow Full definition →	150.40	80.80	47.20	175.00
Working Capital Full definition →	1,172.20	1,167.00	1,152.80	1,323.30
Capital Expenditures Full definition →	(39.10)	(43.20)	(42.70)	(76.10)
Net Current Asset Value Full definition →	724.00	721.30	707.40	884.20
EV/EBIT Full definition →	33.12	37.01	27.06	33.00
Capex to Sales Full definition →	0.04	0.05	0.05	0.09
Price to Operating Income Full definition →	33.45	37.36	27.55	34.01
Other line items
Average Receivables Full definition →	686.60	647.20	614.60	563.45
Average Payables Full definition →	252.60	245.85	240.35	246.50
Average Inventory Full definition →	451.35	434.25	420.65	410.45
Average Assets Full definition →	4,083.25	4,014.60	3,864.00	3,956.70
Average Common Equity Full definition →	3,009.85	2,959.65	2,836.75	2,929.15

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly